Ruixiang Xia

982 total citations
25 papers, 722 citations indexed

About

Ruixiang Xia is a scholar working on Molecular Biology, Hematology and Materials Chemistry. According to data from OpenAlex, Ruixiang Xia has authored 25 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Hematology and 6 papers in Materials Chemistry. Recurrent topics in Ruixiang Xia's work include Quantum Dots Synthesis And Properties (5 papers), Platelet Disorders and Treatments (5 papers) and Chalcogenide Semiconductor Thin Films (4 papers). Ruixiang Xia is often cited by papers focused on Quantum Dots Synthesis And Properties (5 papers), Platelet Disorders and Treatments (5 papers) and Chalcogenide Semiconductor Thin Films (4 papers). Ruixiang Xia collaborates with scholars based in China, Canada and Germany. Ruixiang Xia's co-authors include Xiaoliang Xu, Lixin Zhu, Jiangluqi Song, Mingya Yang, Bin Zhang, Jing Bao, Qingsheng Li, Asad Ali, Linlin Wu and Xiaowen Chen and has published in prestigious journals such as Biochemical and Biophysical Research Communications, ACS Applied Materials & Interfaces and The Journal of Physical Chemistry C.

In The Last Decade

Ruixiang Xia

23 papers receiving 717 citations

Peers

Countries citing papers authored by Ruixiang Xia

Since Specialization

Citations

This map shows the geographic impact of Ruixiang Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruixiang Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruixiang Xia more than expected).

Fields of papers citing papers by Ruixiang Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruixiang Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruixiang Xia. The network helps show where Ruixiang Xia may publish in the future.

Co-authorship network of co-authors of Ruixiang Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Ruixiang Xia. A scholar is included among the top collaborators of Ruixiang Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruixiang Xia. Ruixiang Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A lesson from fatal invasive fungal infections after CAR-T cell therapy: a case report and literature review 2024 ·Immunotherapy ·(unknown), (unknown), Min Ruan, (unknown), (unknown), (unknown), (unknown), Ruixiang Xia, Jian Ge, Zhangbiao Long	3
2	Structure-based discovery of IHMT-IDH1-053 as a potent irreversible IDH1 mutant selective inhibitor 2023 ·European Journal of Medicinal Chemistry ·(unknown), Beilei Wang, Fengming Zou, (unknown), Wenliang Wang, Wei Wang, Qingwang Liu, (unknown), (unknown), Chen Hu, (unknown), Aoli Wang, Tao Huang, Yuying He, Ruixiang Xia, Jian Ge, Jing Liu, Qingsong Liu	3
3	iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma 2022 ·Frontiers in Oncology ·Qinhua Liu, (unknown), Yi Wu, Mingxia Zhang, Mingya Yang, Xiaonan Wang, Mingyue Song, Xiaodan Li, Ruixiang Xia, Zhengsheng Wu	30
4	[Effect of rhTPO and rhIL-11 on Thrombocytopenia after Chemotherapy in Leukemia]. 2022 ·PubMed ·(unknown), Ruixiang Xia	3
5	Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML) 2021 ·European Journal of Pharmacology ·Tingting Lu, (unknown), Fengming Zou, Xixiang Li, Aoli Wang, Wenliang Wang, Huamin Liang, Qingwang Liu, (unknown), Chen Hu, Cheng Chen, Zhenquan Hu, Wenchao Wang, Lili Li, Jian Ge, Yang Shen, Tao Ren, Jing Liu, Ruixiang Xia, Qingsong Liu	8
6	Clinical efficacy and safety of ixazomib in the treatment of multiple myeloma 2021 ·Zhongguo linchuang yaolixue yu zhiliaoxue ·(unknown), (unknown), Xiaowen Chen, (unknown), Hailong Xia, Ruixiang Xia	0
7	LncRNA HCP5 acts as a miR-128-3p sponge to promote the progression of multiple myeloma through activating Wnt/β‐catenin/cyclin D1 signaling via PLAGL2 2021 ·Cell Biology and Toxicology ·Qinhua Liu, (unknown), Mingyue Song, Xiaodan Li, Zhengsheng Wu, (unknown), Ruixiang Xia	21
8	Scutellarin exerts anticancer effects on human leukemia cells via induction of Sub-G1 cell cycle arrest, apoptosis and also inhibits migration and invasion by targeting Raf/MEK/ERK signalling pathway. 2021 ·PubMed ·Jing Bao, Xia Liang, Yucheng Zhao, Ruixiang Xia	6
9	Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell Immunotherapy 2021 ·Frontiers in Immunology ·Mingya Yang, Lei Wang, Ming Ni, Brigitte Neuber, Sanmei Wang, Wenjie Gong, Tim Sauer, Maria‐Luisa Schubert, Angela Hückelhoven‐Krauss, Ruixiang Xia, Jian Ge, Christian Kleist, Volker Eckstein, Leopold Sellner, Carsten Müller‐Tidow, Peter Dreger, Michael Schmitt, Anita Schmitt	14
10	Long Non-coding RNA X-Inactive Specific Transcript Mediates Cell Proliferation and Intrusion by Modulating the miR-497/Bcl-w Axis in Extranodal Natural Killer/T-cell Lymphoma 2020 ·Frontiers in Cell and Developmental Biology ·Qinhua Liu, (unknown), Zhengsheng Wu, Xiaodan Li, Qingshu Zeng, Ruixiang Xia, Yalei Wang	7
11	Network-based analysis with primary cells reveals drug response landscape of acute myeloid leukemia 2020 ·Experimental Cell Research ·Cheng Chen, Li Wang, Lili Li, Aoli Wang, Tao Huang, Jie Hu, Ming Zhao, Feiyang Liu, Shuang Qi, (unknown), Wenliang Wang, Jing Liu, Jian Ge, Ruixiang Xia, Wenchao Wang, Qingsong Liu	5
12	Mutation profile and prognostic relevance in elderly patients with de novo acute myeloid leukemia treated with decitabine‐based chemotherapy 2020 ·International Journal of Laboratory Hematology ·(unknown), Hong Jian, Zhangbiao Long, Qingsheng Li, Ruixiang Xia, Qingshu Zeng	9
13	Ultrathin MoS₂ nanosheets for high-performance photoelectrochemical applications via plasmonic coupling with Au nanocrystals 2019 ·Nanoscale ·Asad Ali, (unknown), Xiaolin Chen, (unknown), Kui Chen, Xiaoliang Xu, Ruixiang Xia, Lixin Zhu	64
14	Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607/FZD3/Wnt/β-catenin pathway 2018 ·Biochemical and Biophysical Research Communications ·Liang Xia, Linlin Wu, Jing Bao, Qingsheng Li, Xiaowen Chen, Hailong Xia, Ruixiang Xia	104
15	Bandgap and Structure Engineering via Cation Exchange: From Binary Ag₂S to Ternary AgInS₂, Quaternary AgZnInS alloy and AgZnInS/ZnS Core/Shell Fluorescent Nanocrystals for Bioimaging 2016 ·ACS Applied Materials & Interfaces ·Jiangluqi Song, Chao Ma, Wenzhe Zhang, Xiaodong Li, Bin Zhang, Rongbo Wu, (unknown), Asad Ali, Mingya Yang, Lixin Zhu, Ruixiang Xia, Xiaoliang Xu	104
16	Tumor cell-targeted Zn₃In₂S₆ and Ag–Zn–In–S quantum dots for color adjustable luminophores 2016 ·Journal of Materials Chemistry B ·Jiangluqi Song, Chao Ma, Bin Zhang, Siyu Yang, Shuhui Wang, Lv Liu, Lixin Zhu, Ruixiang Xia, Xiaoliang Xu	42
17	Plasma Levels of Interleukin 12 Family Cytokines and Their Relevant Cytokines in Adult Patients with Chronic Immune Thrombocytopenia before and after High-Dose Dexamethasome Treatment 2015 ·Medical Principles and Practice ·Qingsheng Li, Linjie Zhang, Ruixiang Xia, Qingshu Zeng, (unknown), Liang Xia, Leiming Xia, Mingzhen Yang	13
18	Analysis of Epidemiological and Clinical Features of 1160 Adult Patients with Immune Thrombocytopenia 2015 ·Journal of Medical Imaging and Health Informatics ·Jing Ni, Qingshu Zeng, Yang Chen, Qingsheng Li, Min Ruan, (unknown), Ruixiang Xia	0
19	Aqueous synthesis of color tunable Cu doped Zn–In–S/ZnS nanoparticles in the whole visible region for cellular imaging 2015 ·Journal of Materials Chemistry B ·Tongtong Jiang, Jiangluqi Song, Huijie Wang, (unknown), Hao Wang, Bin Zhang, Mingya Yang, Ruixiang Xia, Lixin Zhu, Xiaoliang Xu	82
20	Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti‐platelet GPIIbIIIa versus GPIbα antibodies 2011 ·American Journal of Hematology ·Qingshu Zeng, Lingyan Zhu, Lili Tao, Jing Bao, Mingzhen Yang, Elisa Simpson, Conglei Li, Dianne E. van der Wal, Pingguo Chen, Christopher M. Spring, Mingli Wang, Lingjie Zhang, Changgeng Ruan, Ming Hou, Ruixiang Xia, Heyu Ni	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact